Circulating Tumor DNA (ctDNA) in Kidney Cancer: A Narrative Review

Circulating Tumor DNA (ctDNA) in Kidney Cancer: A Narrative Review

Circulating tumor DNA (ctDNA) has been investigated as a potential noninvasive biomarker for disease prognostication, monitoring, and treatment selection in various tumor types, including renal cell carcinoma (RCC). In this narrative review, we explore the current methods of ctDNA anal...

Full description

Bibliographic Details
Main Authors:	Wesley Yip, A. Ari Hakimi
Format:	Article
Language:	English
Published:	The Société Internationale d’Urologie (SIU) 2023-07-01
Series:	Société Internationale d’Urologie Journal
Subjects:	renal cell carcinoma biomarkers ctdna
Online Access:	https://siuj.org/index.php/siuj/article/view/282/232

Similar Items

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis
by: Estela Sánchez-Herrero, et al.
Published: (2022-07-01)

Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer
by: Michael J. Duffy, et al.
Published: (2022-01-01)

Current status of ctDNA in precision oncology for hepatocellular carcinoma
by: Yan Li, et al.
Published: (2021-04-01)

The Role of ctDNA in Gastric Cancer
by: Justin Mencel, et al.
Published: (2022-10-01)

CTNNB1 polymorphism (rs121913407) in circulating tumor DNA (ctDNA) in Egyptian hepatocellular carcinoma patients
by: Marwa A. Abdel-Wahed, et al.
Published: (2022-07-01)

Harnessing ctDNA in Advanced Melanoma: A Promising Tool for Informed Clinical Decisions
by: Rugile Pikturniene, et al.
Published: (2024-03-01)

The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
by: Agnieszka Kopystecka, et al.
Published: (2023-05-01)

Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
by: Xiaoling Wang, et al.
Published: (2024-01-01)

Liquid Biopsy, ctDNA Diagnosis through NGS
by: Chen Lin, et al.
Published: (2021-08-01)

Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy
by: Xiaohong Han, et al.
Published: (2019-10-01)

Circulating Tumor DNA (ctDNA) Clearance May Predict Treatment Response in Neoadjuvant Colorectal Cancer Management
by: Britney Niemann, et al.
Published: (2024-03-01)

Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples
by: Josep Gumà, et al.
Published: (2022-11-01)

The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
by: Edina Dizdarevic, et al.
Published: (2022-04-01)

Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker
by: Li Li, et al.
Published: (2023-12-01)

Role of ctDNA in Breast Cancer
by: Marta Sant, et al.
Published: (2022-01-01)

Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients
by: Mandy Radefeldt, et al.
Published: (2023-11-01)

Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls
by: Holdenrieder Stefan, et al.
Published: (2022-08-01)

Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)
by: Jessica Gasparello, et al.
Published: (2018-06-01)

Copy Number Variation of Circulating Tumor DNA (ctDNA) Detected Using NIPT in Neoadjuvant Chemotherapy-Treated Ovarian Cancer Patients
by: Mina Sharbatoghli, et al.
Published: (2022-07-01)

CTC, ctDNA, and Exosome in Thyroid Cancers: A Review
by: Wenwen Wang, et al.
Published: (2023-09-01)

ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
by: Wang Da, et al.
Published: (2023-05-01)

Prognostic Value of Circulating Tumor DNA (ctDNA) in Oncogene-Driven NSCLC: Current Knowledge and Future Perspectives
by: Eleni Zografos, et al.
Published: (2022-10-01)

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
by: Jiayan Wei, et al.
Published: (2021-10-01)

ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
by: Mahendra Naidoo, et al.
Published: (2021-01-01)

Assessing Circulating Tumour DNA (ctDNA) as a Biomarker for Anal Cancer Management: A Systematic Review
by: Hugo C. Temperley, et al.
Published: (2024-04-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer
by: Aakash Desai, et al.
Published: (2024-02-01)

Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas
by: David Braig, et al.
Published: (2022-09-01)

Blood, Toil, and Taxoteres: Biological Determinants of Treatment-Induced ctDNA Dynamics for Interpreting Tumor Response
by: Christopher T. Boniface, et al.
Published: (2022-05-01)

State of the Art: ctDNA in Upper Gastrointestinal Malignancies
by: Ibone Labiano, et al.
Published: (2023-02-01)

How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks
by: Estelle Bourbon, et al.
Published: (2021-06-01)

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane
by: Dinja T. Kruger, et al.
Published: (2020-03-01)

Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients
by: Lydia Warburton, et al.
Published: (2023-12-01)

Corrigendum: Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response
by: Christopher T. Boniface, et al.
Published: (2023-03-01)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
by: Gui‐Qi Zhu, et al.
Published: (2022-01-01)

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
by: Sakti Chakrabarti, et al.
Published: (2020-09-01)

Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence
by: Giovanni Marchi, et al.
Published: (2024-01-01)

A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs
by: Jianzhu Xie, et al.
Published: (2023-12-01)

Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine
by: Smadar Kahana-Edwin, et al.
Published: (2023-12-01)

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
by: Jacob J. Adashek, et al.
Published: (2021-07-01)